Ad Code: Fabhalta - Rare Blood Disorders - Aug Display Banners HCP Wallboard Extension- Rare Blood Disorders - 100821

Since 2007, complement-inhibiting drugs have enabled people with paroxysmal nocturnal hemoglobinuria (PNH) to live longer, more normal lives. In the second of this two-part series, Physician’s Weekly (PW) spoke with Elizabeth...

Isolated nervous system involvement on initial presentation with histiocytic neoplasms occurs in up to 5% of patients, according to results published in Blood Cancer Journal. Ronald S. Go, MD, and colleagues examined the...

The prevalence of hereditary thrombotic thrombocytopenic purpura (hTTP) is considerably higher than current estimates, according to findings published in Blood Advances. Flora Peyvandi, MD, PhD, and colleagues aimed to provide a...

Fatigue and issues with cognition represented the most common and disabling symptoms associated with myeloproliferative neoplasms, according to findings published in Psycho Oncology . The study team conducted an online survey to...